Researchers



Results 21-40 of 46
Issue DateTitleAuthor(s)TypeМp-cat.
2021Hsa-miR-222 identifies high-risk PTC patients with classical variant architectureStefana Stojanović  ; Sonja Šelemetjev  ; Ilona Đorić ; Jelena Janković Miljuš  ; Vladan Živaljević; Svetislav Tatić; Tijana Išić Denčić  Conference Paper
Mp. category will be shown later
2021Association of two Matrix metalloproteinase-9 promotor polymorphisms and acetylated form of c-jun transcription factor with papillary thyroid carcinoma advancementJelena Rončević  ; Jelena Janković Miljuš  ; Tijana Išić Denčić  ; Svetislav Tatić; Vladan Živaljević; Sonja Šelemetjev  ; Ilona Đorić Conference Paper
Mp. category will be shown later
2021Focal adhesion kinase splicing and protein activation in papillary thyroid carcinoma progressionIgnjatović, Valentina  ; Janković Miljuš, Jelena  ; Rončević, Jelena  ; Tatić, Svetislav; Išić Denčić, Tijana  ; Đorić, Ilona ; Šelemetjev, Sonja  Article
21aM21a
2021TSHR mRNA quantification in circulating thyroid cancer cells shows potential in detecting aggressive forms of DTCJelena Janković Miljuš  ; Rok Košir; Uršula Prosenc Zmrzljak; Vladan Živaljević; Ilona Đorić ; Jelena Rončević  ; Tijana Išić Denčić  ; Sonja Šelemetjev  Conference Paper
Mp. category will be shown later
2021Contemporary molecular-biological investigations of papillary thyroid carcinoma prognostic factors and their potential for application in clinical practiceIlona Đorić ; Jelena Janković Miljuš  ; Sonja Selemetjev  Book parts
Mp. category will be shown later
2020Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutationStojanović, Stefana  ; Šelemetjev, Sonja  ; Đorić, Ilona ; Rončević, Jelena  ; Janković Miljuš, Jelena  ; Živaljević, Vladan  ; Išić-Denčić, Tijana  Article
21aM21a
2020Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinomaPaunovic, Ivan; Šelemetjev, Sonja  ; Išić Denčić, Tijana  ; Đorić, Ilona ; Janković Miljuš, Jelena  ; Rončević, Jelena  ; Cvejić, Dubravka Article
22M22
2019Profiling Circulating MicroRNAs As Serum Biomarkers for Thyroid Cancer Recurrence Before And After Recombinant Human TSH StimulationJelena Janković Miljuš  ; Leon Wert-Lamas; Maria Augusta Guillen-Sacoto; Andrea Martinez-Cano; Pilar santisteban; Garcilaso Riesco-EizaguirreConference Paper
Mp. category will be shown later
2019The prognostic significance of mRNA splice-deletion variant (FAK-Del33), total mRNA FAK and pY397 FAK protein expressions levels in papillary thyroid carcinomaSonja Šelemetjev  ; Valentina Ignjatović  ; Jelena Janković Miljuš  ; Jelena Rončević  ; Ilona Đorić ; Išić Denčić, Tijana M.  ; Dubravka Cvejić Conference Paper
Mp. category will be shown later
2019MMP-9 promotor polymorphisms -1562C>T SNP and microsatellite (CA)13–25x tandem repeats associate with increased MMP-9 expression in papillary thyroid carcinomaJelena Rončević  ; Sonja Selemetjev  ; Jelena Janković Miljuš  ; Išić Denčić, Tijana M.  ; Ilona Djorić ; Dubravka Cvejić Conference Paper
Mp. category will be shown later
2019The effect of the BRAFV600E mutation on the level of expression of BANCR in papillary thyroid carcinomaStefana Stojanović  ; Šelemetjev, Sonja A.  ; Ilona Đorić ; Jelena Rončevič  ; Janković Miljuš, Jelena R.  ; Svetislav Tatić; Išić Denčić, Tijana M.  Conference Paper
Mp. category will be shown later
2019MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progressionRončević, Jelena  ; Đorić, Ilona ; Šelemetjev, Sonja  ; Janković Miljuš, Jelena  ; Išić Denčić, Tijana  ; Bozic, Vesna; Cvejić, Dubravka Article
21M21
2019Cirkulišući biomarkeri karcinoma štitaste žlezde – potencijal serumskih mikro RNK za detekciju rekurentnog karcinoma štitne žlezdeJelena Janković Miljuš  ; Leon wert-Lamas; Maria Augusta Guillen-Sacoto; Andrea Martinez-Cano; Pilar Santisteban; Garcilaso Riesco-EizaguirreConference Paper
Mp. category will be shown later
2019SECRETION OF CANCER-ASSOCIATED MICRORNAS VIA EXOSOMES AFTER TSH STIMULATION OF THYROID CANCER CELLSJanković Miljuš, Jelena R.  ; Sara Muñoz-López; Julia A. Ramirez-Moya; Andrea Martínez- Cano; Pilar Santisteban; Garcilaso Riesco-EizaguirreConference Paper
Mp. category will be shown later
2018Genski polimorfizam, ekspresija, i enzimska aktivnost matriksne metaloproteinaze-9 kao prognostički markeri papilarnog karcinoma štitaste žlezdeIlona Đorić ; Rončević, Jelena V.  ; Sonja Šelemetjev  ; Jelena Janković  ; Tijana Išić Denčić  ; Vesna Božić; Dubravka Cvejić Conference Paper
Mp. category will be shown later
2017Combined determination of caveolin-1, BRAF V600E and EGFR in FNAB samples discriminates patients with high and low risk of aggressive thyroid cancerJanković, Jelena R.  ; Tatić, Svetislav B.  ; Božić, Vesna ; Živaljević, Vladan R.  ; Cvejić, Dubravka S. ; Paskaš, Svetlana D.  Conference Paper
Mp. category will be shown later
2017Inverse expression of caveolin-1 and EGFR in thyroid cancer patientsJanković Miljuš, Jelena  ; Tatić, Svetislav  ; Božić, Vesna; Živaljević, Vladan  ; Cvejić, Dubravka ; Paskaš, Svetlana  Article
21M21
2017MMP9 (-1562C/T) gene polymorphism associates with increased MMP-9 level and papillary thyroid carcinoma progressionIlona Đorić ; Rončević, Jelena V.  ; Sonja Šelemetjev  ; Jelena Janković  ; Vesna Božić; Dubravka Cvejić Conference Paper
Mp. category will be shown later
2015Expression analysis of caveolin-1 in papillary thyroid carcinoma with relation to clinicopathological parameters and BRAF mutation statusJanković, Jelena  ; Paškaš, Svetlana  ; Marečko, Ilona ; Išić, Tijana  ; Tatić, Svetislav  ; Cvejić, Dubravka ; Svetlana Savin-Žegarac Conference Paper
Mp. category will be shown later
2015Malignant risk stratification of thyroid fine needle aspiration specimens using serum, genetic and protein markersJanković, Jelena  ; Živaljević, Vladan  ; Tatić, Svetislav  ; Božić, Vesna ; Cvejić, Dubravka ; Paskaš, Svetlana  Conference Paper
Mp. category will be shown later